Recently, Supreme Court had dismissed pleas by Indian telecom operators to re-compute Adjusted Gross Revenue (AGR) dues. The companies had sought corrections in the AGR calculations, a penalty reduction, and interest rate adjustments. This resulted in significant implications specifically for Vodafone Idea (VIL), whose burden has now increased to Rs 70,320 cr as of FY24. … Read more
The QIP was announced last month at a price of Rs 1850-1880/ share (about 11% discount to the then market price). QIP will result in a 5.54% equity dilution Rs 1000 cr will be utlised in the following manner – Rs 500 cr for organic growth. Capex will be completed by FY26. the medtech industry … Read more
With the objective to take advantage of the upcoming growth opportunities, IDFC First Bank has announced a Rs 3,200 cr preferential issue (current mcap of the Bank is around Rs 55,000 cr). The issue is priced at Rs 80.63/ share. It’s close to the current market price of Rs 77-78/ share. Subscribers to the preferential … Read more
In pursuant to the new fund raising plan approved by Vodafone Idea’s (VIL) Board in February 2024, the Company launched a mega follow-on public offer (FPO) of Rs 18,000 cr. The FPO was offered in the price band of Rs 10 to Rs 11 and was open from April 18 to April 22. The Company … Read more
The Board has approved a new fund raising plan of Rs 45,000 cr. Rs 20,000 cr will be through a mix of equity and equity linked instruments. Balance Rs 25,000 cr will be through debt. Promoters will also participate in the proposed equity raise. No further details are provided for now. The company will complete … Read more
There are two notable developments at Spicejet – It’s interested in looking at the bankrupt Go First for acquisition Has expressed interest to Go First’s Resolution Professional and will submit an offer post diligence Further to it’s recently announced plan to raise fresh capital of $270 mn i.e. Rs 2,254 cr – It has announced … Read more
The Company has announced – Up to 1,25,00,000 (One crore twenty five lakhs) fully convertible equity warrants convertible into equivalent number of Equity Shares of the Company having face value of Rs. 10/- each, at a Premium of Rs 35/- per Warrant, aggregating up to Rs. 56.25 cr 25% of the consideration shall be payable … Read more
Glenmark Pharma (GPL) is selling 75% stake in Glenmark Life Sciences (GLS) to Nirma. GPL currently holds 82.84% in GLS. Post transaction it would be left with 7.84%. The transaction has been agreed at Rs 615/ share implying an equity valuation of Rs 7,535 cr for GLS. GPL will get Rs 5,651.5 cr for 75% … Read more
The Company has agreed to sell 22 acres in Worli to Sumitomo Realty & Development Company Limited, a large commercial real estate investor and developer in the Japanese market. Sale is in two phases Phase 1 –Â Bombay Dyeing (BDMC) will receive about Rs. 4,675 crore from the buyer by October 2023. Phase 2 – … Read more